Included support
- +Hospital matching
- +Record review
- +Care coordination
- +Travel support
- +Interpretation support
CAR-T
Chimeric antigen receptor T-cell therapy (CAR-T) may be considered in non-Hodgkin lymphoma that is relapsed or refractory and remains active after multiple lines of prior therapy, commonly in B-cell lymphomas expressing the corresponding target. The decision is influenced by factors such as patholog
24-72h
Response window
Approx. $39,300
Treatment fee
Not included
- -Treatment fee
- -Travel costs
- -Optional extras
Hospital consultation window
Peking Union Medical College Hospital - Beijing - Grade 3A
Ruijin Hospital - Shanghai - Grade 3A
West China Hospital - Chengdu - Grade 3A
Our service process
Let us coordinate the treatment journey with you.
1
How CAR-T is performed
CAR-T therapy generally begins with leukapheresis to obtain autologous T cells; under experimental conditions, a chimeric antigen receptor is introduced via a vector, enabling them to recognize specific tumor antigens. After quality release, a short course of lymphodepletion therapy is usually given to facilitate cell expansion, followed by CAR-T reinfusion. During this period, vital signs, infection, and neurological status are continuously monitored, and symptomatic and supportive treatment is given as needed. The overall goal is to achieve cell expansion and assess disease response. The above is general health information, not medical advice; specific details are subject to specialist evaluation and hospital protocols.
What is CAR-T?
CAR-T therapy generally begins with leukapheresis to obtain autologous T cells; under experimental conditions, a chimeric antigen receptor is introduced via a vector, enabling them to recognize specific tumor antigens. After quality release, a short course of lymphodepletion therapy is usually given to facilitate cell expansion, followed by CAR-T reinfusion. During this period, vital signs, infection, and neurological status are continuously monitored, and symptomatic and supportive treatment is given as needed. The overall goal is to achieve cell expansion and assess disease response. The above is general health information, not medical advice; specific details are subject to specialist evaluation and hospital protocols.
How is CAR-T performed?
Step 1
How CAR-T is performed
CAR-T therapy generally begins with leukapheresis to obtain autologous T cells; under experimental conditions, a chimeric antigen receptor is introduced via a vector, enabling them to recognize specific tumor antigens. After quality release, a short course of lymphodepletion therapy is usually given to facilitate cell expansion, followed by CAR-T reinfusion. During this period, vital signs, infection, and neurological status are continuously monitored, and symptomatic and supportive treatment is given as needed. The overall goal is to achieve cell expansion and assess disease response. The above is general health information, not medical advice; specific details are subject to specialist evaluation and hospital protocols.
Recovery process
Step 1
Recovery and stay
Including evaluation, collection/preparation, hospitalization, and early follow-up, the overall stay in China is mostly 5–9 weeks; the specific duration depends on the product preparation cycle and individual recovery.
Request a free evaluation
Tell us about your Lymphocytic Leukemia case and we will help match you with the right hospital, specialist, and travel pathway.
Frequently asked questions
How do I get started?⌄
Submit a free evaluation request with your diagnosis and records. The team reviews your case and suggests suitable next steps.
Do I need a visa to travel to China for treatment?⌄
Many patients do. We can help explain what documents are normally needed for treatment travel planning.
Will there be a language barrier?⌄
Medical interpretation can be arranged for consultations and treatment visits.
How much does treatment cost?⌄
Costs depend on the procedure, hospital, and treatment pathway. A practical estimate is provided before travel.
What happens after I return home?⌄
We can help coordinate remote follow-up and keep communication open with your care team.